ARCHIVES

ACS Study Shows Reduced Mortality For Low T/N Brands

This article is from The Cancer Letter archive.

Vol. 06 No. 16 | April 18, 1980

Download PDF Visit The Full Archive

Related Articles

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

March 8, 2002

More Bad News For Estrogen: Increased Ovarian Cancer Risk

July 19, 2002

Patients Prefer Silicone Over Saline Implants

November 26, 2010

Wisconsin Funds State Cancer Control Program

July 15, 1988

In Brief: Shannn Award Selections Made; ACS Funds 431 Grants Worth $50 Mil.; 500 Nurses Pass Exam

August 30, 1991

Bishop: Cells, Genes Reveal Unified Strategy For Cancer Conquest

March 3, 1995